KARPAS 620 Human Plasma Cell Leukemia cell line useful in oncology research, developed at the University of Cambridge.
Publications:
Nacheva et al. (1990). Br J Haematol 74, 70–76
Drexler and Matsuo (2000). Leuk Res 24, 681–703
Cambridge Enterprise Limited is the exclusive licensor for the Karpas cell line portfolio. We have partnered with ECACC (The European Collection of Cell Cultures; a Public Health England Culture Collection) to manage distribution of the majority of these cells on our behalf. Enquires to either organisation are welcomed.
Enquiry for KARPAS 620 Human Plasma Cell Leukaemia cell line
Reagents Enquiry
To find out more about how this website collects your personal data see www.enterprise.cam.ac.uk/about-us/information-compliance/data-protection/core-privacy-notices/website-users-use-personal-information/